Alveolar cleft osteoplasty using tissue-engineered osteogenic material

The use of tissue-engineered osteogenic material comprising platelet-rich plasma and autologous mesenchymal stem cells isolated, expanded and induced to osteogenic potential in bone augmentation procedures as a replacement for autologous bone grafts, offers predictable results with minimal donor-sit...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of oral and maxillofacial surgery Vol. 35; no. 6; pp. 551 - 555
Main Authors Hibi, H., Yamada, Y., Ueda, M., Endo, Y.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ltd 01.06.2006
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The use of tissue-engineered osteogenic material comprising platelet-rich plasma and autologous mesenchymal stem cells isolated, expanded and induced to osteogenic potential in bone augmentation procedures as a replacement for autologous bone grafts, offers predictable results with minimal donor-site morbidity. This material was applied for an alveolar cleft osteoplasty of a 9-year-old female patient. Serial computed tomograms showed the regenerated bone extending from the cleft walls after 3 months and bridging the cleft after 6 months, with 79.1% of the grafted region after 9 months at the time when the canine and lateral incisor in the affected side erupted in the reconstructed alveolar ridge.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0901-5027
1399-0020
DOI:10.1016/j.ijom.2005.12.007